Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of quinidine on platelets.

B H Chong1, I J Kaplin

  • 1Department of Haematology, St. George Hospital, Kogarah, Australia.

Haemostasis
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

High concentrations of quinidine significantly alter platelet structure and function, inhibiting key aggregation pathways. Lower pharmacological doses show variable effects on platelet aggregation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.

Journal of autoimmunity·2021
Same author

Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis.

International journal of laboratory hematology·2018
Same author

Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.

Clinical & experimental metastasis·2015
Same author

Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombocytopenia: communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Beware of NK cells in pre-clinical metastasis models.

Clinical & experimental metastasis·2013
Same author

EGFR and the complexity of receptor crosstalk in the cardiovascular system.

Current molecular medicine·2012

Area of Science:

  • Pharmacology
  • Hematology
  • Biochemistry

Background:

  • Quinidine is an antiarrhythmic drug with known effects on cardiovascular function.
  • Platelets play a crucial role in hemostasis and thrombosis.
  • Understanding drug interactions with platelets is vital for patient safety and therapeutic efficacy.

Purpose of the Study:

  • To investigate the effects of quinidine on platelet ultrastructure and function.
  • To determine the concentration-dependent effects of quinidine on platelet aggregation.
  • To assess the impact of quinidine on various platelet activation pathways.

Main Methods:

  • Studied quinidine effects on platelets across a wide concentration range.
  • Observed ultrastructural changes using microscopy.

Related Experiment Videos

  • Measured 14C-serotonin release from platelets.
  • Assessed platelet aggregation inhibition induced by adenosine diphosphate, adrenaline, collagen, and arachidonate.
  • Evaluated the effect on ristocetin-induced agglutination.

    • Main Results:

    • High quinidine concentrations (1 and 1.5 mM) induced profound ultrastructural changes and 14C-serotonin release.
    • High quinidine concentrations markedly inhibited platelet aggregation stimulated by adenosine diphosphate, adrenaline, collagen, and arachidonate.
    • Quinidine did not affect ristocetin-induced platelet agglutination.
    • A low pharmacological concentration (10 microM) of quinidine had a variable inhibitory effect on adrenaline-induced platelet aggregation.

    Conclusions:

    • Quinidine exerts significant concentration-dependent effects on human platelets.
    • High quinidine concentrations disrupt platelet structure and inhibit multiple aggregation pathways.
    • Quinidine's antiplatelet effects at pharmacological concentrations require further investigation.